Viewing nowPrazinc Tablets (Polaprazinc)
Polaprezinc 75mg
Tablet · Prescription medication
Korea Prime Pharmaceutical Co., Ltd.

MFDS item code 201907576 · Approved 2019.10.30 · Insurance code 663607970
Treatment of gastric ulcers; improvement of gastric mucosal lesions in gastritis
This medication is used for the treatment of gastric ulcers and helps improve damage to the gastric mucosa. It also effectively improves gastric mucosal lesions such as erosion, bleeding, redness, and edema that occur during exacerbation of acute or chronic gastritis. Therefore, it helps restore the health of the gastric mucosa and alleviates symptoms.
Adults: The usual dose is 75 mg (1 tablet) of polaprezinc per dose, taken orally twice daily, after breakfast and before bedtime.
This medication may affect liver function, so if symptoms of liver dysfunction or jaundice occur, discontinue use immediately and consult a physician. As it contains zinc, it may cause copper deficiency; thus, patients with poor nutritional status should receive appropriate treatment if symptoms of anemia or blood abnormalities appear. Hypersensitive reactions such as skin rash, itching, and urticaria may occur, so if these symptoms appear, discontinue use and consult a specialist. During the use of this medication, gastrointestinal symptoms such as constipation, nausea, abdominal bloating, vomiting, heartburn, or diarrhea may occur, so it is important to monitor for these symptoms. In domestic clinical trials and post-marketing studies, nausea and dyspepsia have been reported as the most common side effects, and rarely, severe adverse reactions such as cerebral infarction, seizures, and bleeding may also occur, so if any unusual symptoms occur, consult medical personnel immediately. Caution is required when taking this medication with other drugs, as the effectiveness may be reduced, especially when used concurrently with penicillamine or levothyroxine sodium. Pregnant women or those who could become pregnant should only use this medication when the benefits of treatment outweigh the risks, as its safety has not been established. If breastfeeding, it is advisable to avoid it as the drug may be transmitted through breast milk. Safety in children has not been confirmed, so it is preferable not to use it in pediatric patients. In elderly patients, gastrointestinal function may decline, so doses should be reduced and the patient's condition should be closely monitored.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to prevent air or moisture from entering, and it is safely stored at room temperature between 1 to 30 degrees Celsius. Proper storage will maintain the effectiveness of the medication for a longer period.
White round tablets
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowPolaprezinc 75mg
Tablet · Prescription medication
Korea Prime Pharmaceutical Co., Ltd.

Polaprezinc 75mg
Tablet · Prescription medication
SK Chemicals Co., Ltd.

Polaprezinc 75mg
Tablet · Prescription medication
Hanmi Pharmaceutical Co., Ltd.

Polaprezinc 75mg
Tablet · Prescription medication
Korea Paviz Pharmaceutical Co., Ltd.

Polaprezinc 75mg
Tablet · Prescription medication
Sam-il Pharmaceutical Co., Ltd.
Polaprezinc 75mg
Tablet · Prescription medication
International Pharmaceutical Co., Ltd.
Polaprezinc 75mg
Tablet · Prescription medication
Medix Pharmaceutical Co., Ltd.

Polaprezinc 75mg
Tablet · Prescription medication
Lee Yeon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.